Observational studyJournal of managed care & specialty pharmacy2019

Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population.

Mark A Tesell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.